Blockade of the PGE2 Pathway Inhibits the Growth of PTEN-Deficient HNSCC Tumors

Jacqueline P Nguyen1, Shorook Na'ara1, Liam C Woerner1

  • 1Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California.

PubMed

Insights

Aspirin inhibits head and neck squamous cell carcinoma (HNSCC) growth in PTEN-deficient tumors. Targeting EP2/EP4 receptors with TPST-1495 enhances anti-PD1 therapy effectiveness in HNSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • PI3K signaling is frequently altered in head and neck squamous cell carcinoma (HNSCC).
  • PTEN loss or PIK3CA alterations lead to increased PI3K signaling, promoting tumor growth and immunosuppression via COX2 and prostaglandin E2 (PGE2).
  • The role of PGE2 in PTEN-deficient HNSCC and its interaction with EP2/EP4 receptors require further investigation.

Purpose of the Study:

  • To investigate PGE2 signaling in PTEN-deficient HNSCC.
  • To evaluate the efficacy of aspirin and a dual EP2/EP4 antagonist (TPST-1495) in preclinical HNSCC models.
  • To assess the potential of EP2/EP4 antagonism to enhance anti-PD1 immunotherapy.

Main Methods:

  • Utilized PTEN knockout and PIK3CA-altered HNSCC cell lines and tumor models in immunocompetent mice.
  • Assessed PGE2 signaling pathways and the impact of therapeutic interventions.
  • Administered aspirin, TPST-1495, or anti-PD1 immunotherapy, alone or in combination.

Main Results:

  • Aspirin selectively inhibited the growth of PTEN knockout HNSCC tumors.
  • TPST-1495 demonstrated significant tumor growth inhibition.
  • TPST-1495 substantially enhanced the antitumor activity of anti-PD1 immunotherapy.

Conclusions:

  • Non-steroidal anti-inflammatory drugs (NSAIDs) exhibit antitumor activity in PTEN-deficient and PI3K-altered HNSCC.
  • Targeting EP2/EP4 receptors represents a promising strategy to augment existing anti-PD1 therapies for HNSCC.
  • These findings suggest novel therapeutic avenues for PI3K pathway-altered HNSCC.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
344
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K